Substipharm is a privately held pharmaceutical Group.

We develop, supply and commercialize pharmaceuticals in more than 60 countries worldwide. Our portfolio of products that we currently license out or distribute directly or through partners comprises more than 60 different molecules. Our development pipeline includes as well more than 40 ongoing projects.

We have a successful portfolio of pharmaceutical products and vaccines including:
Mature brands
Generics
Over the counter (OTC) pharmaceuticals
Difficult to develop medicines
Value added presentations
Biological products including vaccines:

Biotechnology

Life Sciences

Medical Devices

Pharmaceutical

SUBSTIPHARM

Leopold Berthier

Jean-Jacques Cavelier

Celine Ly

Cédric Ripert

Catherine Cottenot

Philippe Beaupere

Industrial Affairs and Operations

Regulatory Affairs Team

Leadership Team

Quality Assurance and Pharmacovigilance Team

Teams at SUBSTIPHARM

Industrial Affairs and Operations

Regulatory Affairs Team

Leadership Team

Quality Assurance and Pharmacovigilance Team